- Home
- TRGP vs IQV Comparison
TRGP vs IQV Comparison
Compare TRGP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRGP
- IQV
- Stock Information
- Founded
- TRGP 2005
- IQV 1982
- Country
- TRGP United States
- IQV United States
- Employees
- TRGP N/A
- IQV N/A
- Industry
- TRGP Natural Gas Distribution
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TRGP Utilities
- IQV Health Care
- Exchange
- TRGP Nasdaq
- IQV Nasdaq
- Market Cap
- TRGP 32.1B
- IQV 38.1B
- IPO Year
- TRGP 2010
- IQV 2013
- Fundamental
- Price
- TRGP $207.42
- IQV $201.70
- Analyst Decision
- TRGP Strong Buy
- IQV Buy
- Analyst Count
- TRGP 16
- IQV 16
- Target Price
- TRGP $171.88
- IQV $256.60
- AVG Volume (30 Days)
- TRGP 1.6M
- IQV 2.2M
- Earning Date
- TRGP 11-05-2024
- IQV 10-31-2024
- Dividend Yield
- TRGP 1.45%
- IQV N/A
- EPS Growth
- TRGP 44.82
- IQV 27.98
- EPS
- TRGP 5.53
- IQV 7.62
- Revenue
- TRGP $16,215,700,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- TRGP $13.30
- IQV $3.68
- Revenue Next Year
- TRGP $20.11
- IQV $4.89
- P/E Ratio
- TRGP $37.48
- IQV $26.48
- Revenue Growth
- TRGP N/A
- IQV 3.10
- 52 Week Low
- TRGP $81.03
- IQV $187.62
- 52 Week High
- TRGP $209.79
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- TRGP 83.15
- IQV 36.82
- Support Level
- TRGP $188.54
- IQV $187.62
- Resistance Level
- TRGP $197.14
- IQV $194.48
- Average True Range (ATR)
- TRGP 5.11
- IQV 7.28
- MACD
- TRGP 1.40
- IQV -0.86
- Stochastic Oscillator
- TRGP 94.38
- IQV 29.09
About TRGP Targa Resources Inc.
Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.